Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study.
Ann Oncol
; 31(9): 1160-1168, 2020 09.
Article
in En
| MEDLINE
| ID: mdl-32497736
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Trifluridine
/
Capecitabine
/
Bevacizumab
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2020
Type:
Article